ABBV Anleihen
Unten befindet sich eine Liste von ABBVIE INC CEDEAR EACH 10 REPR 1 COM Unternehmensanleihen. Investoren entscheiden sich oft für Unternehmensanleihen, weil sie eine gesteigerte Stabilität zu Zeiten von erheblichen Marktvolatilitäten bieten. Sehen Sie sich die Preise, Renditen und weitere Daten an. Entdecken Sie eine zuverlässige Investition.
Symbol | YTM % | Coupon % | Verfallsdatum | Ausstehend | Nennwert | Min. Anlagebetrag | Emittent |
|---|---|---|---|---|---|---|---|
| AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6,72% | 4,63% | 2042-10-01 | 67,493 M USD | 1.000,00 USD | 2.000,00 USD | Actavis, Inc. |
| AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 6,21% | 4,75% | 2045-03-15 | 53,51 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
| AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 5,98% | 4,85% | 2044-06-15 | 65,232 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
| AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5,79% | 4,55% | 2035-03-15 | 107,646 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
 ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029 | 5,21% | 3,20% | 2029-11-21 | 62,515 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064 | 5,08% | 5,50% | 2064-03-15 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054 | 4,95% | 5,40% | 2054-03-15 | 3 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| AA5QDALLERGAN FNDG 15/25 | 4,95% | 3,80% | 2025-03-15 | 130,225 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
| ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044 | 4,91% | 4,85% | 2044-06-15 | 1,008 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044 | 4,87% | 5,35% | 2044-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| US287YAW9ABBVIE 16/46 | 4,87% | 4,45% | 2046-05-14 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048 | 4,86% | 4,88% | 2048-11-14 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| 4ABBABBVIE 15/45 | 4,86% | 4,70% | 2045-05-14 | 2,7 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045 | 4,79% | 4,75% | 2045-03-15 | 827,091 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049 | 4,78% | 4,25% | 2049-11-21 | 5,745 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042 | 4,77% | 4,63% | 2042-10-01 | 389,217 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042 | 4,77% | 4,40% | 2042-11-06 | 2,599 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039 | 4,67% | 4,05% | 2039-11-21 | 4 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026 | 4,63% | 2,95% | 2026-11-21 | 9,245 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| US287YAV1ABBVIE 16/36 | 4,51% | 4,30% | 2036-05-14 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035 | 4,47% | 4,55% | 2035-03-15 | 1,681 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| US287YAR0ABBVIE 15/35 | 4,44% | 4,50% | 2035-05-14 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034 | 4,41% | 5,05% | 2034-03-15 | 3 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| 4ABCABBVIE 15/25 | 4,29% | 3,60% | 2025-05-14 | 3,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025 | 4,21% | 3,80% | 2025-03-15 | 2,889 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031 | 4,20% | 4,95% | 2031-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029 | 4,07% | 3,20% | 2029-11-21 | 5,437 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| US287YAY5ABBVIE 16/26 | 4,05% | 3,20% | 2026-05-14 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029 | 3,99% | 4,80% | 2029-03-15 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026 | 3,96% | 2,95% | 2026-11-21 | 3,991 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027 | 3,91% | 4,80% | 2027-03-15 | 2,25 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028 | 3,90% | 4,25% | 2028-11-14 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| XXS162262122ALLERGAN FNDG 17/29 | 3,87% | 2,13% | 2029-06-01 | 36,462 M EUR | 1.000,00 EUR | 100.000,00 EUR | Allergan Funding SCS |
 XS190919331ALLERGAN FNDG 18/28 | 3,60% | 2,63% | 2028-11-15 | 72,107 M EUR | 1.000,00 EUR | 100.000,00 EUR | Allergan Funding SCS |
| ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024 | 3,11% | 2,60% | 2024-11-21 | 3,739 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049 | 3,08% | 4,25% | 2049-11-21 | 4,95 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045 | 3,04% | 4,75% | 2045-03-15 | 5 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| 4ABGABBVIE 19/31 | 2,97% | 1,25% | 2031-11-18 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. |
| ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044 | 2,97% | 4,85% | 2044-06-15 | 100 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| XS212591491ABBVIE 20/29 | 2,84% | 2,13% | 2029-06-01 | 506,088 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. |
| XS212591483ABBVIE 20/28 | 2,83% | 2,63% | 2028-11-15 | 427,793 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. |
| XS152090781ABBVIE 16/28 | 2,80% | 2,13% | 2028-11-17 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. |
| 4ABEABBVIE 19/27 | 2,74% | 0,75% | 2027-11-18 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. |
| ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035 | 2,04% | 4,55% | 2035-03-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025 | 1,63% | 3,80% | 2025-03-15 | 1,268 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024 | −3,63% | 2,60% | 2024-11-21 | 10,86 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042 | — | 4,40% | 2042-11-06 | 1,1 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |
| ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025 | — | 3,80% | 2025-03-15 | — | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |